Valneva SE VALN
NASDAQ VALN
$6.95 -0.11 (-1.63%)
As of: Sep 4, 2026 · 12:37 PM EDT

Valneva SE (VALN) Profit After Tax (2021 - 2026)

Valneva SE (VALN) posted Profit After Tax of $37.5 million for Q1 2026, up 164.48% sequentially from -$58.2 million in Q4 2025, and up 286.67% YoY from $9.7 million in Q1 2025.

Analysis

Valneva SE (VALN) Profit After Tax (2021 - 2026) Analysis & Trends

Valneva SE has reported Profit After Tax for 6 years, with the latest figure at $37.5 million in Q1 2026.

  • Quarterly Profit After Tax rose 286.67% year-over-year to $37.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.0 million (up 32.61% YoY) and the FY2025 annual result came in at -$134.1 million, down 911.65% from the prior year.
  • Profit After Tax improved to $37.5 million in Q1 2026 per VALN's latest filing, from -$58.2 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $155.2 million in Q2 2022 and troughed at -$247.3 million in Q4 2022.
  • A 5-year average of -$22.2 million and a median of -$10.1 million in 2024 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2025 and 2026: Profit After Tax sank 651.16% in 2025, then soared 286.67% in 2026.
  • Over 5 years, Profit After Tax stood at -$247.3 million in 2022, then gained by 25.72% to -$183.7 million in 2023, then jumped by 78.51% to -$39.5 million in 2024, then plunged by 47.52% to -$58.2 million in 2025, then jumped by 164.48% to $37.5 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $37.5 million, -$58.2 million, and -$76.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -16.62 Mn
10 Valneva SE 584.00 Mn 442.75 Mn 1.86 Mn -36.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -36.27 Mn
Mar 31, 2026 -37.55 Mn
Dec 31, 2025 -58.20 Mn
Sep 30, 2025 -51.89 Mn
Jun 30, 2025 -13.11 Mn
Mar 31, 2025 -9.71 Mn
Dec 31, 2024 -39.43 Mn
Sep 30, 2024 -10.19 Mn
Jun 30, 2024 -26.85 Mn
Mar 31, 2024 64.00 Mn
Dec 31, 2023 -34.60 Mn
Sep 30, 2023 -37.26 Mn
Jun 30, 2023 -18.42 Mn
Mar 31, 2023 -19.46 Mn
Dec 31, 2022 -45.10 Mn
Sep 30, 2022 73.02 Mn
Jun 30, 2022 -210.78 Mn
Mar 31, 2022 29.23 Mn
Dec 31, 2021 -365.34 Mn
Sep 30, 2021 391.91 Mn